-
The FDA approved a weight loss drug
US’ Eli Lilly has received Food and Drug Administration’s approval to sell its weight-loss medication Zepbound. The drug is designed to be given at the highest dose of 15 milligrams per day. In a study, people who took it lost an average of 48 pounds, compared to a placebo group’s loss of 22 pounds. Over…
-
Eli Lilly limits the out-of-pocket cost of their drug to $35 a month
US drugmaker Eli Lilly will immediately cap monthly out-of-pocket costs for people who aren’t covered by Medicare at $35 (over 2,300) per month if insurers and the pharmacy system don’t implement its price cuts soon. The average retail price of insulin in the US has gone up in the last few years, reported GoodRx. Over…